Abstract:BACKGROUND: Mounting epidemiological evidence supports a role for phosphatase and tensin homologue (PTEN)-T cell leukaemia 1 (Tcl1) signalling deregulation in hepatocarcinogenesis.OBJECTIVE: To determine the molecular and biochemical mechanisms by which the PTEN/Tcl1 axis regulates the pentose phosphate pathway (PPP) in hepatocellular carcinoma (HCC).METHODS: We compared levels of PTEN and glucose-6-phosphate dehydrogenase (G6PD) mRNA in human HCC and healthy liver tissue. We measured PPP flux, glucose consumption, lactate production, nicotinamide adenine dinucleotide phosphate (NADPH) levels and lipid accumulation. We investigated the PTEN/Tcl1 axis using molecular biology, biochemistry and mass spectrometry analysis. We assessed proliferation, apoptosis and senescence in cultured cells, and tumour formation in mice.RESULTS: We showed that PTEN inhibited the PPP pathway in human liver tumours. Through the PPP, PTEN suppressed glucose consumption and biosynthesis. Mechanistically, the PTEN protein bound to G6PD, the first and rate-limiting enzyme of the PPP and prevented the formation of the active G6PD dimer. Tcl1, a coactivator for Akt, reversed the effects of PTEN on biosynthesis. Tcl1 promoted G6PD activity and also increased G6PD pre-mRNA splicing and protein expression in a heterogeneous nuclear ribonucleoprotein (hnRNPK)-dependent manner. PTEN also formed a complex with hnRNPK, which inhibited G6PD pre-mRNA splicing. Moreover, PTEN inactivated Tcl1 via glycogen synthase kinase-3β (GSK3β)-mediated phosphorylation. Importantly, Tcl1 knockdown enhanced the sensitivity of HCC to sorafenib, whereas G6PD knockdown inhibited hepatocarcinogenesis.CONCLUSIONS: These results establish the counteraction between PTEN and Tcl1 as a key mechanism that regulates the PPP and suggest that targeting the PTEN/Tcl1/hnRNPK/G6PD axis could open up possibilities for therapeutic intervention and improve the prognosis of patients with HCC.

Radiation-Inducible Pten Expression Radiosensitises Hepatocellular Carcinoma Cells

PTEN Expression in U251 Glioma Cells Enhances Their Sensitivity to Ionizing Radiation by Suppressing DNA Repair Capacity.

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Pten Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib

Overexpression of PTEN enhances the sensitivity of human hepatocellular carcinoma HepG2 cells to gefitinib

The Drug-Resistance to Gefitinib in PTEN Low Expression Cancer Cells is Reversed by Irradiation in Vitro

PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis

Activating PTEN by COX-2 inhibitors antagonizes radiation-induced AKT activation contributing to radiosensitization.

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Effect of Tumor Suppressor Gene PTEN on the Resistance to Cisplatin in Human Ovarian Cancer Cell Lines and Related Mechanisms.

Effect of stability of PTEN on hepatocellular carcinoma

Apoptin sensitizes radiation-induced cell death via classic mitochondrial, caspase and p53-dependent signaling in HepG2 cells.

Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.

PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair

PTEN Regulates Angiogenesis and VEGF Expression Through Phosphatase-Dependent and -Independent Mechanisms in HepG2 Cells

Inhibitory Effects of Retrovirus Mediated PTEN Gene on Human Hepatocellular Carcinoma Cell Line

MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma

Radiation-resistant Cancer Stem-Like Cell Properties Are Regulated by PTEN Through the Activity of Nuclear Β-Catenin in Nasopharyngeal Carcinoma.

HRD1-mediated PTEN Degradation Promotes Cell Proliferation and Hepatocellular Carcinoma Progression.

Pterostilbene Increases PTEN Expression Through the Targeted Downregulation of Microrna-19A in Hepatocellular Carcinoma

PTEN Inhibits the Migration and Invasion of HepG2 Cells by Coordinately Decreasing MMP Expression Via the PI3K/Akt Pathway